XBIT
XBIT
NASDAQ · Biotechnology

Xbiotech Inc

$2.27
-0.04 (-1.73%)
As of Mar 29, 10:44 PM ET ·
Financial Highlights (FY 2025)
Revenue
51.54M
Net Income
-6,374,638
Gross Margin
36.5%
Profit Margin
-12.4%
Rev Growth
+3.4%
D/E Ratio
0.61
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 36.5% 36.5% 36.5%
Operating Margin -10.2% -10.6% -9.2%
Profit Margin -12.4% -13.6% -11.1%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 51.54M 48.92M 53.08M
Gross Profit 18.83M 17.88M 19.40M
Operating Income -5,264,657 -5,204,024 -4,863,525
Net Income -6,374,638 -6,659,114 -5,888,081
Gross Margin 36.5% 36.5% 36.5%
Operating Margin -10.2% -10.6% -9.2%
Profit Margin -12.4% -13.6% -11.1%
Rev Growth +3.4% -7.2% +0.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 34.70M 43.16M 36.51M
Total Equity 56.50M 61.66M 62.33M
D/E Ratio 0.61 0.70 0.59
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -7,191,271 -7,364,625 -7,497,793
Free Cash Flow -8,326,283 -5,338,476 -7,416,749